Addus HomeCare Co. (NASDAQ:ADUS) Shares Sold by Dean Investment Associates LLC

Dean Investment Associates LLC decreased its holdings in Addus HomeCare Co. (NASDAQ:ADUS - Free Report) by 80.0% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 4,922 shares of the company's stock after selling 19,721 shares during the quarter. Dean Investment Associates LLC's holdings in Addus HomeCare were worth $655,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors also recently bought and sold shares of ADUS. Wasatch Advisors LP increased its holdings in shares of Addus HomeCare by 11.8% in the 3rd quarter. Wasatch Advisors LP now owns 1,043,240 shares of the company's stock valued at $138,782,000 after purchasing an additional 110,010 shares in the last quarter. Point72 Asset Management L.P. grew its position in Addus HomeCare by 73.4% during the second quarter. Point72 Asset Management L.P. now owns 745,824 shares of the company's stock worth $86,598,000 after buying an additional 315,602 shares during the period. Dimensional Fund Advisors LP increased its holdings in Addus HomeCare by 0.8% in the second quarter. Dimensional Fund Advisors LP now owns 714,253 shares of the company's stock valued at $82,930,000 after buying an additional 5,421 shares in the last quarter. State Street Corp lifted its position in shares of Addus HomeCare by 4.4% during the 3rd quarter. State Street Corp now owns 663,610 shares of the company's stock valued at $88,280,000 after acquiring an additional 27,990 shares during the period. Finally, Principal Financial Group Inc. boosted its stake in shares of Addus HomeCare by 17.5% during the 3rd quarter. Principal Financial Group Inc. now owns 505,853 shares of the company's stock worth $67,293,000 after acquiring an additional 75,409 shares in the last quarter. Institutional investors and hedge funds own 95.35% of the company's stock.

Analysts Set New Price Targets

Several equities analysts recently issued reports on the company. Stephens lifted their price objective on Addus HomeCare from $143.00 to $145.00 and gave the stock an "overweight" rating in a report on Wednesday, November 6th. StockNews.com downgraded Addus HomeCare from a "buy" rating to a "hold" rating in a research note on Tuesday, December 3rd. Royal Bank of Canada reissued an "outperform" rating and issued a $136.00 price objective on shares of Addus HomeCare in a research note on Thursday, November 14th. Macquarie restated an "outperform" rating and set a $139.00 target price on shares of Addus HomeCare in a report on Monday, November 4th. Finally, KeyCorp began coverage on shares of Addus HomeCare in a report on Friday, October 11th. They issued an "overweight" rating and a $150.00 price target on the stock. One research analyst has rated the stock with a sell rating, one has issued a hold rating, seven have given a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average target price of $131.63.

Addus HomeCare Trading Down 0.0 %

Shares of Addus HomeCare stock traded down $0.02 during trading hours on Monday, reaching $120.72. 93,393 shares of the company's stock were exchanged, compared to its average volume of 130,666. The firm has a market capitalization of $2.19 billion, a price-to-earnings ratio of 27.62, a price-to-earnings-growth ratio of 2.11 and a beta of 1.02. Addus HomeCare Co. has a 52-week low of $85.94 and a 52-week high of $136.12. The company has a fifty day moving average of $126.01 and a 200-day moving average of $124.24.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last posted its quarterly earnings results on Monday, November 4th. The company reported $1.30 earnings per share for the quarter, topping analysts' consensus estimates of $1.28 by $0.02. The company had revenue of $289.80 million for the quarter, compared to the consensus estimate of $289.42 million. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. Addus HomeCare's revenue was up 7.1% on a year-over-year basis. During the same quarter last year, the firm posted $1.03 earnings per share. On average, equities research analysts anticipate that Addus HomeCare Co. will post 4.59 earnings per share for the current fiscal year.

Insiders Place Their Bets

In related news, Director Esteban Lopez sold 500 shares of the business's stock in a transaction dated Tuesday, September 10th. The stock was sold at an average price of $127.50, for a total value of $63,750.00. Following the transaction, the director now owns 3,366 shares in the company, valued at approximately $429,165. The trade was a 12.93 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CEO R Dirk Allison sold 12,500 shares of the stock in a transaction dated Monday, November 25th. The shares were sold at an average price of $123.16, for a total value of $1,539,500.00. Following the completion of the transaction, the chief executive officer now directly owns 141,897 shares of the company's stock, valued at $17,476,034.52. This represents a 8.10 % decrease in their position. The disclosure for this sale can be found here. 4.60% of the stock is currently owned by insiders.

Addus HomeCare Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.